Premium
[P‐204]: A 5 year double blind, randomised trial on EGb 761® efficacy on the prevention of Alzheimer's dementia in patients over 70 with memory complaint. Guidage study
Author(s) -
Vellas Bruno,
Andrieu Sandrine,
Ousset Pierre-Jean,
Ouzid Mehemed,
Mathiex-Fortunet Hélène
Publication year - 2005
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2005.06.262
Subject(s) - medicine , placebo , anxiety , dementia , depression (economics) , randomized controlled trial , psychiatry , pediatrics , disease , alternative medicine , pathology , economics , macroeconomics
P-204 A 5 YEAR DOUBLE BLIND, RANDOMISED TRIAL ON EGB 761® EFFICACY ON THE PREVENTION OF ALZHEIMER’S DEMENTIA IN PATIENTS OVER 70 WITH MEMORY COMPLAINT. GUIDAGE STUDY Bruno Vellas, Sandrine Andrieu, Pierre-Jean Ousset, Mehemed Ouzid, Hélène Mathiex-Fortunet, and GUIDAGE Group; CHU, Toulouse, France; INSERM 558, Toulouse, France; IPSEN, Paris, France; G. Berrut, Angers, JF Dartigues, Bordeaux, B Dubois, Paris, H Grandjean, Toulouse, E Leger-Picherit,Paris, F Pasquier, Lille, F Piette, Paris, Ph Robert, Nice, J Touchon, Montpellier, France